+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice



Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice



Arthritis Care and Research 63(12): 1680-1690



The Veterans Affairs (VA) Rheumatoid Arthritis (VARA) registry and the VA Pharmacy Benefits Management database were linked to determine the association of methotrexate (MTX) adherence with rheumatoid arthritis (RA) disease activity. For each patient, the medication possession ratio (MPR) was calculated for the first episode of MTX exposure of a duration of ≥12 weeks for both new and established MTX users. High MTX adherence was defined as an MPR ≥0.80 and low MTX adherence was defined as an MPR <0.80. For each patient, the mean Disease Activity Score with 28 joints (DAS28) score, erythrocyte sedimentation rate (ESR), and C-reaction protein (CRP) level observed during registry followup were compared in high- versus low-adherence groups. In 455 RA patients, the prescribed doses of MTX (mean ± SD 16 ± 4 mg versus 16 ± 4 mg; P = 0.6) were similar in high-adherence patients (n = 370) in comparison to low-adherence patients (n = 85). However, the actual observed MTX doses taken by patients were significantly higher in the high-adherence group (mean ± SD 16 ± 5 mg versus 11 ± 3 mg; P < 0.001). DAS28 (mean ± SD 3.6 ± 1.2 versus 3.9 ± 1.5; P < 0.02), ESR (mean ± SD 24 ± 18 versus 29 ± 24 mm/hour; P = 0.05), and CRP level (mean ± SD 1.2 ± 1.3 versus 1.6 ± 1.5 mg/dl; P < 0.03) were lower in the high-adherence group compared to those with low MTX adherence. These variances were not explained by differences in baseline demographic features, concurrent treatments, or whether MTX was initiated before or after VARA enrollment. High MTX adherence was associated with improved clinical outcomes in RA patients treated with MTX. Adjustment for potential confounders did not alter the estimated effect of adherence. These results demonstrate the advantages of being able to merge clinical observations with pharmacy databases to evaluate antirheumatic drugs in clinical practice.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036198815

Download citation: RISBibTeXText

PMID: 21905260

DOI: 10.1002/acr.20629


Related references

Utility of administrative and clinical data to predict major change in medical treatment in US Veterans enrolled in the Veterans Affairs Rheumatoid Arthritis (VARA) registry. Clinical and Experimental Rheumatology 37(4): 552-560, 2018

THU0115Factors Associated with Methotrexate Treatment Duration, Including Subcutaneous Use, in Patients with Rheumatoid Arthritis: Observations from the Veterans Affairs Database. Annals of the Rheumatic Diseases 73(Suppl 2): 217.3-218, 2014

THU0091Treatment Pattern and Disease Activity Scores in Rheumatoid Arthritis Patients; Data Taken from Qatar Rheumatoid Arthritis Registry. Annals of the Rheumatic Diseases 75(Suppl 2): 212.1-212, 2016

Evaluation of different methods used to assess disease activity in rheumatoid arthritis: analyses of abatacept clinical trial data. Annals of the Rheumatic Diseases 68(4): 484-489, 2009

Measures of rheumatoid arthritis disease activity. Arthritis Care & Research 63(Suppl. 11): S14-S36, 2012

Agreement between Rheumatologist and Patient-reported Adherence to Methotrexate in a US Rheumatoid Arthritis Registry. Journal of Rheumatology 43(6): 1027-1029, 2016

SAT0065Effectiveness and Drug Adherence of Biologic Monotherapy in Danish Rheumatoid Arthritis Patients: A Cohort Study of Clinical Practice in the Danbio Registry. Annals of the Rheumatic Diseases 73(Suppl 2): 613.2-614, 2014

Adherence to clinical practice guidelines for the treatment of candidemia at a Veterans Affairs Medical Center. International Journal of Health Sciences 11(3): 18-23, 2017

Clinical pharmacy practice in the noninstitutional setting. A white paper from the American College of Clinical Pharmacy. The ACCP Clinical Practice Affairs Committee, 1990-1991. PharmacoTherapy 12(4): 358-364, 1992

Minimum practice standards for clinical pharmacy specialists with interpretation for organized health-care settings. Clinical Practice Affairs Committee of the American College of Clinical Pharmacy, 1985-86. Drug Intelligence & Clinical Pharmacy 21(7-8): 645-647, 1987

AB0193The Utility of Using Administrative Data To Stratify US Veterans with Rheumatoid Arthritis on The Basis of Disease Activity:. Annals of the Rheumatic Diseases 75(Suppl 2): 963.2-963, 2016

FRI0113Persistence and Adherence with Triple Therapy and Tumor Necrosis Factor Inhibitor-Methotrexate Combination Therapy in us Veterans with Rheumatoid Arthritis. Annals of the Rheumatic Diseases 74(Suppl 2): 460.3-461, 2015

Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study. Annals of the Rheumatic Diseases 72(1): 64-71, 2013

THU0078Moderate Alcohol Consumption Is Not Associated with Serum Liver Abnormalities in Patients with Rheumatoid Arthritis Taking Methotrexate: Data from The Clinical Practice Research Database (CPRD):. Annals of the Rheumatic Diseases 75(Suppl 2): 207.2-207, 2016

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry. Arthritis and Rheumatism 62(1): 22-32, 2010